Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

SU-F-T-659: Nanoparticle-Aided Eye Plaque Radiotherapy

Journal Article · · Medical Physics
DOI:https://doi.org/10.1118/1.4956845· OSTI ID:22649214
 [1];  [2]
  1. University of Masschusetts-Lowell, Lowell, Massachusetts (United States)
  2. Harvard Medical School, Boston, MA (United States)
Purpose: Eye plaque brachytherapy is one of the approaches for radiotherapy treatment for ocular cancers: retinoblastoma and choroidal melanoma. This study, investigates the potential benefits of using gold nanoparticles to enhance therapeutic efficacy during eye plaque brachytherapy. Methods: The EYE PHYSICS Inc. Plaque Simulator program distributed by IsoAid, LLC, Port Richey, Florida was used. It is based on the superposition of dose contributions from individual seeds following the TG–43 formalism. Dose enhancement factor (DEF) values for feasible nanoparticle concentrations from previous studies was used to investigate the benefit of using nanoparticles to enhance dose to tumour or reduce dose to healthy tissue. The dose enhancement factor (DEF) represents the ratio of the dose deposited in tumour with nanoparticles divided by dose deposited in the tumour without nanoparticles. The investigation was done for I–125 and Pd–103 typical sources employed for eye plaque brachytherapy. The prescription dose used is 85 Gy. Results: Lower dose enhancement values were obtained for Pd–103. With DEF of 2 due to gold nanoparticles, critical structure doses reduce by a factor of 2. Optic disc dose is 6.69 Gy and 4.571 Gy, opposite retina dose is 4.064 and 2.484 Gy, lens dose is 12.66 Gy and 9.870 Gy, and fovea dose is 9.85 Gy and 7.275 Gy. With DEF of 3 due to gold nanoparticles, critical structure doses reduce by a factor of 3. Optic disc dose is 4.352 Gy and 2.975 Gy, opposite retina dose is 2.644 Gy and 1.618 Gy, lens dose is 8.322 Gy and 6.427 Gy, and fovea dose is 4.815 Gy and 4.737 Gy. Conclusion: The results of this research predict that using gold nanoparticles will lead to major sparing of dose to critical structures. The finding provides more impetus for the development of nanoparticle–aided brachytherapy.
OSTI ID:
22649214
Journal Information:
Medical Physics, Journal Name: Medical Physics Journal Issue: 6 Vol. 43; ISSN 0094-2405; ISSN MPHYA6
Country of Publication:
United States
Language:
English

Similar Records

Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy
Journal Article · Sun Nov 14 23:00:00 EST 1993 · International Journal of Radiation Oncology, Biology and Physics; (United States) · OSTI ID:7066135

Lack of Radiation Maculopathy After Palladium-103 Plaque Radiotherapy for Iris Melanoma
Journal Article · Sun Jul 15 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:22058943

Monte Carlo dosimetry for {sup 125}I and {sup 103}Pd eye plaque brachytherapy
Journal Article · Sun Dec 14 23:00:00 EST 2008 · Medical Physics · OSTI ID:22095281